ADVANZ Pharma Corp. Limited - Update on Formal Sale Process
PR Newswire
London, January 21
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE
21 January 2021
Update on Formal Sale Process
About 70 companies raised prices, albeit at a lower rate than in recent years
The drug industry in recent years has faced growing scrutiny from patients, lawmakers and health plans over the prices of its products.
Photo: Steven Senne/Associated Press
By Updated Jan. 1, 2021 8:56 pm ET
The pharmaceutical industry is raising the prices of many products in the new year, albeit at a rate slightly below the past couple of years.
GlaxoSmithKline PLC and Sanofi SA are among the companies that raised the prices of hundreds of drugs by an average of 3.3%, according to a new analysis.
Pfizer Inc., which has a large portfolio of.